PetCaseFinder

Peer-reviewed veterinary case report

Near infrared fluorescence helps find lymph nodes in dogs with mast

By Chiti, L E et al.·Published in Veterinary and comparative oncology·2025·Clinic for Small Animal Surgery·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: SHINE - Validation of Near Infrared Fluorescence Lymphography Against Lymphoscintigraphy for Sentinel Lymph Node Biopsy in Dogs With Mast Cell Tumours.

Species:
dog

Plain-English summary

A group of 48 dogs with mast cell tumors (a type of skin cancer) underwent a procedure to remove sentinel lymph nodes, which help determine if the cancer has spread. Half of the dogs had a new imaging technique called near-infrared fluorescence lymphography (NIRF-L) used during surgery, while the other half did not. The results showed that NIRF-L was just as effective as the traditional method, lymphoscintigraphy, in finding the lymph nodes, but it made the surgery quicker and required smaller incisions. This suggests that NIRF-L is a promising option for improving surgical outcomes in dogs with mast cell tumors.

People also search for: dog mast cell tumor treatment · sentinel lymph node biopsy in dogs · NIRF-L for dog cancer surgery

Abstract

Lymphoscintigraphy is the gold standard among sentinel lymph node (SLN) mapping techniques. Unfortunately, lymphoscintigraphy is not readily accessible, leading to the need for validation of alternative techniques. The aim of this study is to compare near-infrared fluorescence lymphography (NIRF-L) with lymphoscintigraphy for SLN resection in MCT and assess the impact of intraoperative NIRF guidance. Forty-eight dogs with 60 MCT were included in this prospective, blinded, randomised controlled trial. Dogs underwent preoperative lymphoscintigraphy and were then randomised into two groups: in the treatment group (n&#x2009;=&#x2009;30) intraoperative NIRF-L was performed; in the control group (n&#x2009;=&#x2009;30) no intraoperative guidance was implemented. Detection rate, concordance, sensitivity, and negative predictive values were recorded for NIRF-L and lymphoscintigraphy. Surgical time and length of surgical incision were compared between treatment and control groups with the Wilcoxon test (5% significance). Detection rate was 100% for NIRF-L and 98% for lymphoscintigraphy. Discordance occurred in one case. Sensitivity of NIRF-L was 93.7% (95% C.I. 74.3%-99.3%) and negative predictive value ranged between 91.1% and 98.6% with a prevalence of nodal metastases of 61% and 18%. Based on the overlapping of the confidence intervals, NIRF-L was not statistically different to lymphoscintigraphy for sensitivity. Lymphadenectomy was unsuccessful in 4/30 (13%) cases in the control group. Surgical time and incision were significantly shorter in the treatment group (p&#x2009;<&#x2009;0.001; p&#x2009;=&#x2009;0.001). Based on our results, NIRF-L is a valid alternative to lymphoscintigraphy for SLN removal in MCT. Moreover, it improves the success of lymphadenectomy, reduces surgical time, and incision length compared to an unguided technique.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40211779/